Session

Oncology, transplantation and encephalopathy (Posters)

SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA
SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA

Oncology, transplantation and encephalopathy (Posters)  et al.

PREVALENCE AND PREDICTORS OF MALNUTRITION IN PATIENTS WITH HEPATOCELLULAR CANCER – A PROSPECTIVE STUDY FROM A REFERRAL CANCER CENTER
PREVALENCE AND PREDICTORS OF MALNUTRITION IN PATIENTS WITH HEPATOCELLULAR CANCER – A PROSPECTIVE STUDY FROM A REFERRAL CANCER CENTER

Oncology, transplantation and encephalopathy (Posters)  et al.

ULTRASONOGRAPHIC SCORING SYSTEM OF SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE IN PEDIATRIC PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
ULTRASONOGRAPHIC SCORING SYSTEM OF SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE IN PEDIATRIC PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

Oncology, transplantation and encephalopathy (Posters)  et al.

THE FIRST EVIDENCE OF LIVER MICRO ANATOMICAL, MOLECULAR AND METABOLIC CHANGES IN PATIENTS WITH MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY
THE FIRST EVIDENCE OF LIVER MICRO ANATOMICAL, MOLECULAR AND METABOLIC CHANGES IN PATIENTS WITH MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY

Oncology, transplantation and encephalopathy (Posters)  et al.

A PROPENSITY MATCHED ANALYSIS OF PERFORMING VERSUS NOT PERFORMING RENAL REPLACEMENT THERAPY PRIOR TO LIVER TRANSPLANT IN END STAGE LIVER DISEASE PATIENTS WITHOUT CONCOMITANT KIDNEY DISEASE
A PROPENSITY MATCHED ANALYSIS OF PERFORMING VERSUS NOT PERFORMING RENAL REPLACEMENT THERAPY PRIOR TO LIVER TRANSPLANT IN END STAGE LIVER DISEASE PATIENTS WITHOUT CONCOMITANT KIDNEY DISEASE

Oncology, transplantation and encephalopathy (Posters)  et al.

KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR
KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR

Oncology, transplantation and encephalopathy (Posters)  et al.

ROLE OF SERUM MICRORNA‑192 AS A POTENTIAL SERUM MARKER OF HCV RELATED HEPATOCELLULAR CARCINOMA
ROLE OF SERUM MICRORNA‑192 AS A POTENTIAL SERUM MARKER OF HCV RELATED HEPATOCELLULAR CARCINOMA

Oncology, transplantation and encephalopathy (Posters)  et al.

RANDOMIZED COMPARATIVE STUDY TO ASSESS THE EFFICACY OF INJECTABLE L-ORNITHINE L-ASPARTATE VERSUS ORAL L-ORNITHINE L-ASPARTATE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY IN CIRRHOSIS
RANDOMIZED COMPARATIVE STUDY TO ASSESS THE EFFICACY OF INJECTABLE L-ORNITHINE L-ASPARTATE VERSUS ORAL L-ORNITHINE L-ASPARTATE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY IN CIRRHOSIS

Oncology, transplantation and encephalopathy (Posters)  et al.

PREDICTORS OF EXTRAHEPATIC RECURRENCE AFTER TRANSARTERIAL CHEMOEMBOLIZATION AS FIRST-LINE THERAPY FOR HEPATOCELLULAR CARCINOMA
PREDICTORS OF EXTRAHEPATIC RECURRENCE AFTER TRANSARTERIAL CHEMOEMBOLIZATION AS FIRST-LINE THERAPY FOR HEPATOCELLULAR CARCINOMA

Oncology, transplantation and encephalopathy (Posters)  et al.

THE IMPACT OF NUCLEOS(T)IDE ANALOGUES ON THE WAITING LIST FOR LIVER TRANSPLANTATION IN A SINGLE TERTIARY CENTER
THE IMPACT OF NUCLEOS(T)IDE ANALOGUES ON THE WAITING LIST FOR LIVER TRANSPLANTATION IN A SINGLE TERTIARY CENTER

Oncology, transplantation and encephalopathy (Posters)  et al.

THE IMPACT OF NUCLEOS(T)IDE ANALOGUES ON THE WAITING LIST FOR LIVER TRANSPLANTATION IN A SINGLE TERTIARY CENTER
THE IMPACT OF NUCLEOS(T)IDE ANALOGUES ON THE WAITING LIST FOR LIVER TRANSPLANTATION IN A SINGLE TERTIARY CENTER

PREVALENCE AND PREDICTORS OF MALNUTRITION IN PATIENTS WITH HEPATOCELLULAR CANCER – A PROSPECTIVE STUDY FROM A REFERRAL CANCER CENTER
PREVALENCE AND PREDICTORS OF MALNUTRITION IN PATIENTS WITH HEPATOCELLULAR CANCER – A PROSPECTIVE STUDY FROM A REFERRAL CANCER CENTER

THE FIRST EVIDENCE OF LIVER MICRO ANATOMICAL, MOLECULAR AND METABOLIC CHANGES IN PATIENTS WITH MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY
THE FIRST EVIDENCE OF LIVER MICRO ANATOMICAL, MOLECULAR AND METABOLIC CHANGES IN PATIENTS WITH MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY

KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR
KLF5 UPREGULATION IS A COMMON EVENT IN CHOLANGIOCARCINOMA, ACTING AS AN ONCOGENE AND CONSTITUTING A BAD PROGNOSTIC FACTOR

RANDOMIZED COMPARATIVE STUDY TO ASSESS THE EFFICACY OF INJECTABLE L-ORNITHINE L-ASPARTATE VERSUS ORAL L-ORNITHINE L-ASPARTATE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY IN CIRRHOSIS
RANDOMIZED COMPARATIVE STUDY TO ASSESS THE EFFICACY OF INJECTABLE L-ORNITHINE L-ASPARTATE VERSUS ORAL L-ORNITHINE L-ASPARTATE FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY IN CIRRHOSIS

SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA
SCAVENGER RECEPTOR MARCO IS ASSOCIATED WITH AN IMMUNOSUPPRESSIVE MICROENVIRONMENT AND TUMOR PROGRESSION IN INTRAHEPATIC CHOLANGIOCARCINOMA

ULTRASONOGRAPHIC SCORING SYSTEM OF SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE IN PEDIATRIC PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
ULTRASONOGRAPHIC SCORING SYSTEM OF SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE IN PEDIATRIC PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

A PROPENSITY MATCHED ANALYSIS OF PERFORMING VERSUS NOT PERFORMING RENAL REPLACEMENT THERAPY PRIOR TO LIVER TRANSPLANT IN END STAGE LIVER DISEASE PATIENTS WITHOUT CONCOMITANT KIDNEY DISEASE
A PROPENSITY MATCHED ANALYSIS OF PERFORMING VERSUS NOT PERFORMING RENAL REPLACEMENT THERAPY PRIOR TO LIVER TRANSPLANT IN END STAGE LIVER DISEASE PATIENTS WITHOUT CONCOMITANT KIDNEY DISEASE

ROLE OF SERUM MICRORNA‑192 AS A POTENTIAL SERUM MARKER OF HCV RELATED HEPATOCELLULAR CARCINOMA
ROLE OF SERUM MICRORNA‑192 AS A POTENTIAL SERUM MARKER OF HCV RELATED HEPATOCELLULAR CARCINOMA

PREDICTORS OF EXTRAHEPATIC RECURRENCE AFTER TRANSARTERIAL CHEMOEMBOLIZATION AS FIRST-LINE THERAPY FOR HEPATOCELLULAR CARCINOMA
PREDICTORS OF EXTRAHEPATIC RECURRENCE AFTER TRANSARTERIAL CHEMOEMBOLIZATION AS FIRST-LINE THERAPY FOR HEPATOCELLULAR CARCINOMA

Item 1 - 20 / 20
1